Goldman Sachs Sees Nuplazid Label Expansion for Acadia Pharmaceuticals (ACAD), Reiterates Buy
Go back to Goldman Sachs Sees Nuplazid Label Expansion for Acadia Pharmaceuticals (ACAD), Reiterates Buy| Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) | Delayed: 28.24 -0.14 (0.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.38 | 52 Week High | $42.49 | |||
| Open | $28.26 | 52 Week Low | $16.64 | |||
| Day High | $28.43 | P/E | N/A | |||
| Day Low | $27.90 | EPS | $-0.42 | |||
| Volume | 1,062,579 | |||||
